Quarterly report pursuant to Section 13 or 15(d)

REGISTERED DIRECT OFFERING 2017 (Details Textual)

v3.7.0.1
REGISTERED DIRECT OFFERING 2017 (Details Textual) - USD ($)
 1 Months Ended 6 Months Ended
Mar. 03, 2017
Feb. 24, 2017
Feb. 20, 2017
Mar. 31, 2017
Mar. 31, 2016
Sep. 30, 2016
Sep. 28, 2016
Sep. 30, 2013
Repayments of Notes Payable       $ 1,000,000 $ 0      
Derivative Liability   $ 2,996,110            
Massachusetts Life Sciences Center [Member]                
Class of Warrant or Right, Exercise Price of Warrants or Rights               $ 0.27
Qualified Financing, Minimum Net Proceeds             $ 5,000,000  
Repayments of Notes Payable $ 830,000 830,000            
REGISTERED DIRECT OFFERING 2017 [Member]                
Shelf Registration Statement, Maximum Amount Authorized           $ 50,000,000    
Stock Issued During Period, Shares, New Issues     10,166,664          
Shares Issued, Price Per Share     $ 0.60          
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 0.75          
Stock Issued During Period, Value, New Issues   6,100,000            
Number Of Warrants Per Unit     0.55          
Cash Price Per Each Common Stock Underlying Warrants   0.18            
Allocation Of Remaining Proceeds To Common Stock And Additional Paid In Capital   3,103,888            
REGISTERED DIRECT OFFERING 2017 [Member] | Series F Warrant [Member]                
Stock Issued During Period, Value, New Issues   $ 6,100,000